{
  "retracted": false,
  "timestamp": 1510012800000,
  "updates": [
    {
      "timestamp": 1585479609878,
      "identifier": {
        "doi": "10.1038/s41598-017-14858-z"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/s41598-017-03058-4"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation"
}
